Conti-Fine BM - Search Results

1

Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes.

Monfardini C, Milani M, Ostlie N, Wang W, Karachunski PI, Okita DK, Lindstrom J, Conti-Fine BM. Monfardini C, et al. J Neuroimmunol. 2002 Feb;123(1-2):123-34. doi: 10.1016/s0165-5728(01)00454-4. J Neuroimmunol. 2002. PMID: 11880157

2

Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.

Ostlie N, Milani M, Wang W, Okita D, Conti-Fine BM. Ostlie N, et al. J Immunol. 2003 Jan 1;170(1):604-12. doi: 10.4049/jimmunol.170.1.604. J Immunol. 2003. PMID: 12496449

3

T cells and cytokines in the pathogenesis of acquired myasthenia gravis.

Milani M, Ostlie N, Wang W, Conti-Fine BM. Milani M, et al. Ann N Y Acad Sci. 2003 Sep;998:284-307. doi: 10.1196/annals.1254.032. Ann N Y Acad Sci. 2003. PMID: 14592887

4

The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.

Wang W, Ostlie NS, Conti-Fine BM, Milani M. Wang W, et al. Among authors: conti fine bm. J Immunol. 2004 Jan 1;172(1):97-103. doi: 10.4049/jimmunol.172.1.97. J Immunol. 2004. PMID: 14688314

5

CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.

Milani M, Ostlie N, Wu H, Wang W, Conti-Fine BM. Milani M, et al. Among authors: conti fine bm. J Neuroimmunol. 2006 Oct;179(1-2):152-62. doi: 10.1016/j.jneuroim.2006.07.004. Epub 2006 Aug 30. J Neuroimmunol. 2006. PMID: 16945426

6

Myasthenia gravis: past, present, and future.

Conti-Fine BM, Milani M, Kaminski HJ. Conti-Fine BM, et al. J Clin Invest. 2006 Nov;116(11):2843-54. doi: 10.1172/JCI29894. J Clin Invest. 2006. PMID: 17080188 Free PMC article. Review.

7

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.

Wang W, Milani M, Ostlie N, Okita D, Agarwal RK, Caspi RR, Conti-Fine BM. Wang W, et al. Among authors: conti fine bm. J Immunol. 2007 Jun 1;178(11):7072-80. doi: 10.4049/jimmunol.178.11.7072. J Immunol. 2007. PMID: 17513756 Free PMC article.

8

CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis.

Conti-Fine BM, Milani M, Wang W. Conti-Fine BM, et al. Ann N Y Acad Sci. 2008;1132:193-209. doi: 10.1196/annals.1405.042. Ann N Y Acad Sci. 2008. PMID: 18567869 Review.

9

Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice.

Karachunski PI, Ostlie N, Bellone M, Infante AJ, Conti-Fine BM. Karachunski PI, et al. Scand J Immunol. 1995 Aug;42(2):215-25. doi: 10.1111/j.1365-3083.1995.tb03648.x. Scand J Immunol. 1995. PMID: 7631155

10

Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis.

Wang ZY, Okita DK, Howard J Jr, Conti-Fine BM. Wang ZY, et al. Neurology. 1997 Jun;48(6):1643-53. doi: 10.1212/wnl.48.6.1643. Neurology. 1997. PMID: 9191781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters